{"log_id": 5221784787662940858, "direction": 0, "words_result_num": 38, "words_result": [{"probability": {"variance": 0.026015, "average": 0.8761, "min": 0.4669}, "location": {"width": 770, "top": 377, "height": 50, "left": 386}, "words": "发生率增加井可见母性,发育毒性的飞响剂量200mg/kgc"}, {"probability": {"variance": 0.033841, "average": 0.819214, "min": 0.404011}, "location": {"width": 919, "top": 413, "height": 57, "left": 436}, "words": "眭性大鼠在妊和乳期给药,在量为15kg天(按mgm2算相当于MH"}, {"probability": {"variance": 0.030822, "average": 0.880823, "min": 0.351546}, "location": {"width": 987, "top": 457, "height": 59, "left": 386}, "words": "时可见仔骨异常,出生前心或出生后生长迟;在判量为180mg/天(mg/m2"}, {"probability": {"variance": 0.033623, "average": 0.852099, "min": 0.399462}, "location": {"width": 987, "top": 500, "height": 61, "left": 388}, "words": "推算当干MRHD的6,可见幼怀死率增加到子代行为异营该试验中发育操性"}, {"probability": {"variance": 0.042376, "average": 0.781596, "min": 0.376565}, "location": {"width": 967, "top": 546, "height": 61, "left": 386}, "words": "的无为7mgg,未见明显的母体深性。大在妊策3期和整个啡乳期结药"}, {"probability": {"variance": 0.041301, "average": 0.797711, "min": 0.385553}, "location": {"width": 992, "top": 592, "height": 59, "left": 388}, "words": "剂量至180m/k天(按mnm2推算相当于MHD的倍).未见对发官和哥体的不良最"}, {"probability": {"variance": 0, "average": 0.986967, "min": 0.986967}, "location": {"width": 29, "top": 660, "height": 29, "left": 395}, "words": "响"}, {"probability": {"variance": 0.057984, "average": 0.741396, "min": 0.410185}, "location": {"width": 80, "top": 701, "height": 32, "left": 390}, "words": "致癌"}, {"probability": {"variance": 0.041443, "average": 0.81269, "min": 0.363892}, "location": {"width": 939, "top": 722, "height": 59, "left": 443}, "words": "大食祛予左乙西104周,量为50.30和1811mgk天(高剂mg/m3"}, {"probability": {"variance": 0.046882, "average": 0.784533, "min": 0.37171}, "location": {"width": 967, "top": 765, "height": 59, "left": 395}, "words": "或茶承算当MHD的6倍,未见性小鼠食法中婚乙位两坦80周"}, {"probability": {"variance": 0.03702, "average": 0.823932, "min": 0.391585}, "location": {"width": 985, "top": 809, "height": 61, "left": 400}, "words": "剂量为6门、240和90mg/kgk(高剂量mn或量算准当干MRH的2借)."}, {"probability": {"variance": 0.027128, "average": 0.893345, "min": 0.421672}, "location": {"width": 823, "top": 857, "height": 57, "left": 397}, "words": "见,但由于给药剂量低:能充分估对该动物种属的潜在癌性"}, {"probability": {"variance": 7.9e-05, "average": 0.991214, "min": 0.975963}, "location": {"width": 166, "top": 916, "height": 36, "left": 402}, "words": "【药代动力学】"}, {"probability": {"variance": 0.021537, "average": 0.88601, "min": 0.503707}, "location": {"width": 944, "top": 939, "height": 61, "left": 445}, "words": "左乙拉西坦是极易干溶解和兴有高渗透性的化合物,全线性谢,个体内个体间差"}, {"probability": {"variance": 0.033595, "average": 0.854071, "min": 0.355097}, "location": {"width": 996, "top": 983, "height": 64, "left": 395}, "words": "异小多次给药,不能其清除率。本品没有性别、种族异和生周期变异。市品的药"}, {"probability": {"variance": 0.028266, "average": 0.904975, "min": 0.363678}, "location": {"width": 731, "top": 1035, "height": 54, "left": 397}, "words": "代动力学研究显示康志思者和人的药代动力学数据具有可比性"}, {"probability": {"variance": 0.035659, "average": 0.87836, "min": 0.431424}, "location": {"width": 946, "top": 1072, "height": 64, "left": 448}, "words": "于左乙拉西的完全性和线性关系,其血药浓度可以根据口附量gkg进行"}, {"probability": {"variance": 0.036073, "average": 0.87478, "min": 0.378387}, "location": {"width": 605, "top": 1127, "height": 54, "left": 400}, "words": "预测,因没有必要对左乙拉坦进行血药浓度的监控"}, {"probability": {"variance": 0.03023, "average": 0.882271, "min": 0.358344}, "location": {"width": 944, "top": 1161, "height": 61, "left": 450}, "words": "成人及儿童患的液和血药浓度显有显苦的相关性(用本品片剂或本品液体制剂"}, {"probability": {"variance": 0.02653, "average": 0.865978, "min": 0.464409}, "location": {"width": 466, "top": 1220, "height": 45, "left": 425}, "words": "小时后,液f液浓度比是117"}, {"probability": {"variance": 0.001177, "average": 0.96366, "min": 0.912193}, "location": {"width": 153, "top": 1273, "height": 34, "left": 404}, "words": "成人和青少年"}, {"probability": {"variance": 1.7e-05, "average": 0.992831, "min": 0.988684}, "location": {"width": 57, "top": 1321, "height": 29, "left": 402}, "words": "吸收"}, {"probability": {"variance": 0.010574, "average": 0.932148, "min": 0.553251}, "location": {"width": 946, "top": 1337, "height": 61, "left": 454}, "words": "左乙拉坦经门后迅速吸收,服绝对生物利用度接近10%。药13小时后,翻"}, {"probability": {"variance": 0.02671, "average": 0.841337, "min": 0.403925}, "location": {"width": 1001, "top": 1380, "height": 64, "left": 402}, "words": "药浓度达,如果每给药2次,2天后达到段坪液度,如果单剂量为1C0mg及13g"}, {"probability": {"variance": 0.048466, "average": 0.856717, "min": 0.393994}, "location": {"width": 996, "top": 1424, "height": 66, "left": 404}, "words": "每两次,典型的液为31和4al.吸时间与剂无关,摄物不吸收程"}, {"probability": {"variance": 0, "average": 0.992822, "min": 0.992822}, "location": {"width": 29, "top": 1502, "height": 27, "left": 406}, "words": "度"}, {"probability": {"variance": 0.020943, "average": 0.853764, "min": 0.709045}, "location": {"width": 54, "top": 1543, "height": 32, "left": 409}, "words": "分布"}, {"probability": {"variance": 0.034182, "average": 0.872704, "min": 0.388192}, "location": {"width": 944, "top": 1556, "height": 66, "left": 459}, "words": "目前世有人体组织分布的数据。无论尼左拉西还是其主要代产物均不与浆蛋"}, {"probability": {"variance": 0.035233, "average": 0.820487, "min": 0.420166}, "location": {"width": 649, "top": 1614, "height": 54, "left": 409}, "words": "白经(<1%):分布容积为0.5-07Lg,接近人体水积"}, {"probability": {"variance": 0.041784, "average": 0.868127, "min": 0.514674}, "location": {"width": 105, "top": 1675, "height": 29, "left": 411}, "words": "生物转运"}, {"probability": {"variance": 0.03961, "average": 0.827524, "min": 0.385548}, "location": {"width": 951, "top": 1689, "height": 64, "left": 461}, "words": "左乙拉人体内井不广泛分解,主要代谢途径是游过水的乙酰胺化结药量"}, {"probability": {"variance": 0.040872, "average": 0.806321, "min": 0.396375}, "location": {"width": 996, "top": 1730, "height": 70, "left": 413}, "words": "的2)主代训产物UCB105,并不肝色P450转运体系化而来。内大部分组"}, {"probability": {"variance": 0.03515, "average": 0.846826, "min": 0.432204}, "location": {"width": 829, "top": 1783, "height": 59, "left": 413}, "words": "织包括血均定乙酰胺基团水解物,代谢产物UCBL057药理活件"}, {"probability": {"variance": 0.030307, "average": 0.895665, "min": 0.412342}, "location": {"width": 948, "top": 1819, "height": 66, "left": 464}, "words": "2个少代途径也已经确定:个是羟化吐烷途径(给药剂量1.6%),另外咯"}, {"probability": {"variance": 0.044759, "average": 0.781162, "min": 0.390799}, "location": {"width": 372, "top": 1886, "height": 38, "left": 416}, "words": "烷基团开环大约占鼠的09"}, {"probability": {"variance": 0.049554, "average": 0.818268, "min": 0.363617}, "location": {"width": 761, "top": 1895, "height": 86, "left": 466}, "words": "不能够的代谢途径的代谢产物占药剂量的"}, {"probability": {"variance": 0.043168, "average": 0.826859, "min": 0.427647}, "location": {"width": 759, "top": 1954, "height": 68, "left": 470}, "words": "月体外试验效据表明论是左乙西坦玉是其主代挫"}, {"probability": {"variance": 0.046448, "average": 0.81365, "min": 0.386098}, "location": {"width": 743, "top": 2000, "height": 66, "left": 468}, "words": "体外试验据表左乙坦排主产肝色P4"}], "language": 3}